ATE296115T1 - Ortsspezifische arzneimittel verabreichung - Google Patents

Ortsspezifische arzneimittel verabreichung

Info

Publication number
ATE296115T1
ATE296115T1 AT98903970T AT98903970T ATE296115T1 AT E296115 T1 ATE296115 T1 AT E296115T1 AT 98903970 T AT98903970 T AT 98903970T AT 98903970 T AT98903970 T AT 98903970T AT E296115 T1 ATE296115 T1 AT E296115T1
Authority
AT
Austria
Prior art keywords
site
drug administration
specific drug
compounds
localization
Prior art date
Application number
AT98903970T
Other languages
English (en)
Inventor
David S Dime
Peter Backx
Klaus Kimmeldirk
Original Assignee
David S Dime
Peter Backx
Klaus Kimmeldirk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by David S Dime, Peter Backx, Klaus Kimmeldirk filed Critical David S Dime
Application granted granted Critical
Publication of ATE296115T1 publication Critical patent/ATE296115T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/555Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound pre-targeting systems involving an organic compound, other than a peptide, protein or antibody, for targeting specific cells
    • A61K47/557Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound pre-targeting systems involving an organic compound, other than a peptide, protein or antibody, for targeting specific cells the modifying agent being biotin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00Anaesthetics
    • A61P23/02Local anaesthetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Anesthesiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AT98903970T 1997-02-20 1998-02-19 Ortsspezifische arzneimittel verabreichung ATE296115T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US4291197P 1997-02-20 1997-02-20
US6663597P 1997-11-11 1997-11-11
PCT/CA1998/000133 WO1998036777A1 (en) 1997-02-20 1998-02-19 Site-specific drug delivery

Publications (1)

Publication Number Publication Date
ATE296115T1 true ATE296115T1 (de) 2005-06-15

Family

ID=26719776

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98903970T ATE296115T1 (de) 1997-02-20 1998-02-19 Ortsspezifische arzneimittel verabreichung

Country Status (10)

Country Link
US (1) US20060009375A1 (de)
EP (1) EP0966304B1 (de)
JP (1) JP2001513081A (de)
AT (1) ATE296115T1 (de)
AU (1) AU735791B2 (de)
CA (1) CA2281493A1 (de)
DE (1) DE69830305T2 (de)
IL (1) IL131445A0 (de)
NZ (1) NZ337924A (de)
WO (1) WO1998036777A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19926154A1 (de) * 1999-06-09 2000-12-14 Ktb Tumorforschungs Gmbh Verfahren zur Herstellung einer injizierbaren Arzneimittelzubereitung
IL154853A0 (en) * 2000-10-27 2003-10-31 Chiron Spa Nucleic acids and proteins from streptococcus groups a & b
IL161673A0 (en) * 2004-04-29 2004-09-27 Applied Research Systems Compositions and methods for therapy of chemotherapy-induced neuropathy
EP1832575A1 (de) 2006-03-06 2007-09-12 Sulfidris S.r.l. Entzündungshemmende Mittel
JP5653215B2 (ja) 2007-09-12 2015-01-14 ノバルティス アーゲー Gas57変異体抗原およびgas57抗体
ITMI20072215A1 (it) * 2007-11-22 2009-05-23 Sulfidris S R L Nuovi composti anticancro
CN103717239B (zh) * 2011-08-02 2017-08-01 希格马托制药工业公司 适合于吸入的氧化抗生物素蛋白的药物组合物
US11315181B2 (en) 2014-12-31 2022-04-26 Chicago Mercantile Exchange Inc. Compression of price data

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4386026A (en) * 1981-04-20 1983-05-31 Merck & Co., Inc. Cell-specific glycopeptide ligands
CA2016584C (en) * 1989-05-17 1999-06-29 Robert S. Greenfield Anthracycline conjugates having a novel linker and methods for their production
US5612034A (en) * 1990-10-03 1997-03-18 Redcell, Inc. Super-globuling for in vivo extended lifetimes
WO1992020371A1 (en) * 1991-05-10 1992-11-26 Celtrix Pharmaceuticals, Inc. Targeted delivery of bone growth factors
US5723589A (en) * 1995-12-21 1998-03-03 Icn Pharmaceuticals Carbohydrate conjugated bio-active compounds
US5840733A (en) * 1996-07-01 1998-11-24 Redcell, Canada, Inc. Methods and compositions for producing novel conjugates of thrombin inhibitors and endogenous carriers resulting in anti-thrombins with extended lifetimes

Also Published As

Publication number Publication date
AU6202798A (en) 1998-09-09
CA2281493A1 (en) 1998-08-27
US20060009375A1 (en) 2006-01-12
IL131445A0 (en) 2001-01-28
WO1998036777A1 (en) 1998-08-27
DE69830305D1 (de) 2005-06-30
EP0966304A1 (de) 1999-12-29
DE69830305T2 (de) 2006-02-02
JP2001513081A (ja) 2001-08-28
AU735791B2 (en) 2001-07-12
EP0966304B1 (de) 2005-05-25
NZ337924A (en) 2002-09-27

Similar Documents

Publication Publication Date Title
GEP20053474B (en) Glucocorticoid Receptor Modulators
BR9912694A (pt) Composto para preparar medicamento de administração pulmonar
LU91037I2 (fr) Somatulina autogel
TR199801180T2 (xx) Aneljestik etkiye sahip yeni bile�ikler.
IS4566A (is) Lyfjablanda til að gefa í gegnum húð
ATE122668T1 (de) Diarylsubstituierte heterocyclische verbindung, ihre herstellung und arzneimittel und kosmetika daraus.
NO975931D0 (no) Blanding for administrering av medikament
HU229443B1 (en) Betha-carboline particulate form, pharmaceutical compositions containing it, their preparations and their use
LTIP1731A (en) Substituted 4-phenyl-4-piperidinecarboxamides with both local anaesthetic and analgesic effect as well as processes for their preparation
MY118828A (en) Substituted amino compounds and their use as substances having an analgesic effect
PT921787E (pt) Regime de administracao de inibidores de atpase de h',k'
TR199900336T2 (xx) EAA antagonistleri olarak tetrahidrokinolin t�revleri.
GEP20012516B (en) Tricyclic Compounds Having Activity Specific for Integring, Particularly , avB3 Integrins, Method for Preparation the Same as Drugs and Pharmaceutical Composition Containing Same
DE69824313D1 (de) Sibutramin und orlistat enthaltende pharmazeutische zusammensetzungen
HUP9801128A2 (hu) Fukopeptidek, eljárás azok előállítására és alkalmazására, valamint ilyen vegyületeket tartalmazó gyógyszerkészítmények
ATE296115T1 (de) Ortsspezifische arzneimittel verabreichung
DE69434652D1 (de) Antikonvulsive pseudofructopyranose sulfamate
NO975140D0 (no) Transdermalt terapeutisk system (TTS) for administrasjon av testosteron
TR199801184T2 (xx) Analjezik tesirli yeni bile�ikler.
HUP9702448A2 (hu) Indolkarbonsavat tartalmazó, parenterálisan adható gyógyászati készítmény
MX9709453A (es) Composicion farmaceutica oral de compuestos de piperidinoalcanol en forma de solucion.
GEP20043225B (en) 1-Trifluoromethyl-4-Hydroxy-7- Piperidinyl-Aminomethylchroman Derivatives
CA2331414A1 (en) Transdermal therapeutic system for the administration of candesartan
GB1487638A (en) Dibenzo-(b,d)pyran dispersions
GB9420748D0 (en) 1,5 benzodiazepine derivatives

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties